BioCurate and Neurosciences Victoria enter into a Memorandum of Understanding
Victorian Government makes $10m contribution to the $80m BioCurate initiative, to accelerate drug development.
In an Australian first, the Victorian Government in partnership with Monash University and the University of Melbourne, today launched an $80 million enterprise that will help to accelerate the development of quality medicines to treat a wide range of diseases.
A newly launched $80 million enterprise marks a unique collaboration between Monash University and the University of Melbourne in the field of biomedical research.
A first for Australia, and one of a small number of similar initiatives globally, the enterprise taps into the outstanding and complementary biomedical research capabilities and successful pharmaceutical outcomes of the University of Melbourne and Monash University with their associated Medical Research Institutes and hospitals. Both universities rank in the top 50 universities worldwide for Medicine, Pharmacy and Pharmacology according to the latest QS rankings. When the research strengths of these universities are combined in selected therapeutic areas they would be placed in the top 10 institutions globally, so combining their capabilities produces a global scale venture.